For-profit nursing homes more likely than non-profits to be cited for poor quality
For-profit nursing homes are much more likely than their non-profit counterparts to be cited for deficient quality, according to a UCSF/Harvard study.
University of California San Francisco
Displaying 16291 - 16320 of 16507
-
-
Inhibitory switch found for master regulator of inflammation, Gladstone reseachers report
Researchers at the Gladstone Institute of Virology and Immunology have now discovered a new pathway by which the cell regulates the activity of NF-kB, setting the stage for new therapeutic approaches.
-
Seizure treatment en route to hospital safe and effective, study shows
Potentially life threatening seizures can be safely treated by paramedics using injections of Valium or similar benzodiazepine drugs en route to the hospital, rather than waiting for hospital staff to administer the drugs.
-
Consumers should consider eight basic categories when evaluating nursing homes, say UCSF researchers
UCSF researchers have identified the most useful dimensions for measuring and reporting nursing home quality.
-
Fine needle biopsy accurate in the hands of trained practitioners, UCSF study finds
Thoroughly training doctors to perform fine needle biopsies dramatically increases diagnostic accuracy, UCSF researchers have reported.
-
Folic acid, vitamin B12 show potential as heart disease treatments
Folic acid and vitamin B12 offer cost-effective treatments for heart disease and the reduction of associated deaths among the adult U.S. population, according to projections in a new University of California, San Francisco study.
-
The skin's acid coating: SFVAMC researchers explain its origin and how it maintains skin integrity
Your skin is coated with acid. While that might sound disturbing, the mild acidity of the skin's surface actually helps to maintain the strength and cohesiveness of the skin...
-
HIV infection from receptive oral sex is a rare event, UCSF study confirms
A study by researchers from UCSF's Center for AIDS Prevention Studies (CAPS) found the probability of HIV infection through unprotected receptive oral sex with a man to be statistically estimated as zero.
-
UCSF study finds two old drugs may help fight prion diseases
UCSF researchers have determined that two drugs currently approved to treat either malaria or certain psychotic illnesses are effective in treating mouse cells infected with the infectious protein known as the prion (PREE-on).
-
Patent rights stimulate R&D, but fall short in helping poor countries obtain lifesaving drugs
In a report published this month, world health leaders emphasize that intellectual property protection may not be enough to address the larger problem of how to get cheap drugs to poor countries.
-
UCSF studies abused women and state mandatory reporting law
A UCSF study of mandatory reporting of domestic violence to the police examined the attitudes of female emergency department patients and found that nearly half (44.3 percent) of abused women in the study do not support this state law.
-
First vaccine to protect against vaginal transmission of HIV-like virus
University of California scientists have developed the first vaccine that protects against vaginal transmission of a virus closely related to HIV.
-
Illegal drug users should not be denied treatment for Hepatitis C, say UCSF researchers
UCSF researchers are recommending that illicit drug users should be eligible to receive treatment for the hepatitis C virus.
-
Gladstone Researchers Find Clue to Alzheimer's Disease Risk Factor
For years, scientists have recognized that a protein called apoE4 is a major risk factor for developing Alzheimer's disease.
-
"Gene Pill" patent extended to include all proteins secreted into blood
The first patent for a method of inducing insulin production by delivering normal genes in a pill, granted just two months ago to the University of California, San Francisco, now is joined by a second patent issued today...
-
Gladstone researchers discover possible Achilles Heel in infection by lethal Ebola and Marburg virus
The folate receptor, a protein expressed on the surface of many human cells, could be capable of transporting much more into the cell than just folic acid - the B vitamin involved in normal bodily functions and cell development.
-
Progress "stalled" in controlling tobacco use in California
California's tobacco control program is "stalled and adrift," and thousands of people will die needlessly as a result, according to a new report published by the Institute for Health Policy Studies in the School of Medicine at the University of California, San Francisco.
-
Multi center study finds "AIDS cocktail" therapy effective in advanced AIDS cases
Highly active anti-retroviral therapy (HAART), also known as "AIDS cocktail" therapy, is saving lives and preventing infections even in the most advanced AIDS patients, according to a new study.
-
Uninsured patients don't manage chronic illness well, UCSF study finds
Compared to insured health care consumers, uninsured people are much less effective at managing their illnesses.
-
Genes crucial in the control of Tuberculosis found by Gladstone researchers
Controlling a tuberculosis infection requires an interplay of a distinct set of genes and immune system cells. Researchers at the Gladstone Institute of Cardiovascular Disease are showing for the first time that the absence of one of those genes, called CCR2, can have fatal consequences.
-
Chemokine receptor gene crucial in the control of Tuberculosis, Gladstone/UCSF researchers find
Researchers are showing for the first time that the absence of the gene for CCR2, a receptor on white blood cells known to be important for cell migration, can have fatal consequences.
-
UCSF scientists halt tumor growth by manipulating Telomerase enzyme
UCSF researchers report that they were able to slow the growth of human cancer cells - or cause them to commit suicide altogether -- by creating just a miniscule mutation in the telomerase enzyme.
-
Scientists decipher "Fail-Safe" system that limits gene copying cells
Our cells constantly flirt with disaster: Before each division, they duplicate hundreds -- often thousands -- of DNA snippets from each chromosome...
-
Long-term study sorts out the risks for HPV infection and cervical lesions
More than half of sexually active young women will be infected with human papilloma virus (HPV) if they remain sexually active over three years, a UCSF study shows. That risk is boosted 10-fold with each new partner.
-
From flies to humans - ancient gene may be involved in male infertility
UCSF researchers have discovered a human gene that can be traced back through the mouse to the fly, illuminating a molecular nugget from ancient times that may play a crucial role in male fertility - and infertility.
-
Gene that directs fate of many embryonic stem cells identified
Scientists have identified the gene that prompts embryonic stem cells to generate precursors to most internal organs.
-
UCSF study shows short-term delay in AIDS progression is possible even when patients fail to take al
UCSF researchers have found that HIV-infected homeless and marginally housed people who have trouble sticking to their antiviral regimens may temporarily delay the onset of full blown AIDS if they manage to take at least half of their anti-HIV medications.
-
Some women may have gene sequence that reduces breast cancer risk, SFVAMC study finds
Some postmenopausal women carry a gene sequence that may lower their risk of breast cancer, according to new research from San Francisco Veterans Affairs Medical Center.
-
Local death, life-threatening reactions to "Ecstasy" recently
A recent increase in severe reactions to the street drug "Ecstasy" has prompted the San Francisco division of California Poison Control System (CPCS) to renew alerts about the drug's dangers.
-
HIV-positive women at high risk for pre-cancerous anal lesions, study shows
HIV-positive women are three times more likely than other women to develop lesions that can lead to anal cancer, new research shows. The greater risk is due at least in part to weakened immune defenses against the common sexually transmitted human papillomavirus (HPV).